US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OS Therapies

1.55

-0.0400-2.52%

Post-market: 1.560.0100+0.65%19:30 EDT

Volume:438.88K

Turnover:663.36K

Market Cap:71.49M

PE:-1.47

High:1.55

Open:1.50

Low:1.46

Close:1.59

52wk High:2.54

52wk Low:1.15

Shares:46.13M

Float Shares:33.71M

Volume Ratio:0.91

T/O Rate:1.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0524

EPS(LYR):-0.9829

ROE:-914.04%

ROA:-232.65%

PB:-6.00

PE(LYR):-1.58

Loading ...

Overview Company News Filings

OS Therapies Incorporated (OSTX) Gets a Buy from Lake Street

OS Therapies Enters USD 10 Million Line of Credit Backed by U.K. VAT, R&D Tax Credits

OS Therapies Secures Convertible Note Financing for Expansion

Os Therapies - Enters Agreement for up to $10 Mln Senior Secured Convertible Note on June 30- SEC Filing

THOMSON REUTERS

OS Therapies Names Chief Medical Advisor Craig Eagle to Board

OS Therapies Seeks FDA Alignment on 3-year Overall Survival Endpoint for Ost-her2 Accelerated Approval Bid

OS Therapies Unit OS Animal Health Posts Peer-reviewed Data for Ost-her2 in Canine Osteosarcoma Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

OS Therapies says OST-HER2 Phase 2b trial posts 75% 2.5-year survival in resected metastatic osteosarcoma

OS Therapies to release 2.5-year overall survival data from Phase 2b OST-HER2 osteosarcoma trial at ASCO 2026

OS Therapies to present 2.5-year overall survival data at ASCO 2026

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and OS Therapies Incorporated (OSTX)

OS Therapies Is Maintained at Buy by Lake Street

OS Therapies price target lowered to $13 from $14 at Lake Street

OS Therapies Q1 EPS $(0.27) Misses $(0.18) Estimate

Benzinga Earnings

OS Therapies Q1 FY26 net loss widens to $10.4 million; no revenue

OS Therapies Delays Quarterly SEC Filing

OS Therapies delays filing quarterly report after close process takes longer

OS Therapies to report Q1 2026 financial results, give business update

Stonegate Capital Partners updates coverage on OS Therapies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/OSTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","market":"US","secType":"STK","nameCN":"OS Therapies","latestPrice":1.55,"timestamp":1787601600000,"preClose":1.59,"halted":0,"volume":438883,"hourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.55,"latestTime":"19:30 EDT","volume":645,"amount":1001.4055,"timestamp":1787614207063,"change":0.01,"changeRate":0.006452,"amplitude":0.012903},"delay":0,"changeRate":-0.025157232704402538,"floatShares":33708100,"shares":46125800,"eps":-1.05241,"marketStatus":"Closed","change":-0.04,"latestTime":"08-24 16:00:00 EDT","open":1.5,"high":1.55,"low":1.4602,"amount":663364.7640369,"amplitude":0.056478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.05241,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"listingDate":1719460800000,"exchange":"AMEX","adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.51,"preClose":1.59,"latestTime":"09:25 EDT","volume":13687,"amount":20358.919768,"timestamp":1787577918670,"change":-0.08,"changeRate":-0.050314,"amplitude":0.075472},"postHourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.55,"latestTime":"19:30 EDT","volume":645,"amount":1001.4055,"timestamp":1787614207063,"change":0.01,"changeRate":0.006452,"amplitude":0.012903},"volumeRatio":0.905397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","floatShares":33708100,"roa":"-232.65%","roe":"-914.04%","lyrEps":-0.982926,"volumeRatio":0.905397,"shares":46125800,"dividePrice":0,"high":1.55,"amplitude":0.056478,"preClose":1.59,"low":1.4602,"week52Low":1.15,"pbRate":"-6.00","week52High":2.5365,"institutionHeld":0,"latestPrice":1.55,"eps":-1.05241,"divideRate":0,"volume":438883,"delay":0,"ttmEps":-1.05241,"open":1.5,"prevYearClose":1.4,"prevWeekClose":1.59,"prevMonthClose":1.52,"prevQuarterClose":1.9,"fiveDayClose":1.47,"twentyDayClose":1.53,"sixtyDayClose":1.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OSTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1783828800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OSTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OSTX","date":"2026-08-21","current":-1.47281,"percent":0.994208,"low":-14.897496,"twenty":-8.123117,"median":-4.411096,"eighty":-2.573055,"high":-1.629046,"avg":-5.20719,"sd":3.23803,"marketCap":70370207},"quantilePoints":[{"date":"2024-06-14","current":-13.217965,"twenty":-13.216533,"median":-13.214385,"eighty":-13.212238,"marketCap":102988885},{"date":"2024-06-21","current":-10.574372,"twenty":-13.217965,"median":-13.214385,"eighty":-12.156232,"marketCap":82391108},{"date":"2024-06-28","current":-13.217965,"twenty":-13.217965,"median":-13.217965,"eighty":-13.210806,"marketCap":102988885},{"date":"2024-08-02","current":-6.458845,"twenty":-13.217965,"median":-13.217965,"eighty":-11.101659,"marketCap":50324634},{"date":"2024-08-09","current":-8.117559,"twenty":-13.217965,"median":-10.433676,"eighty":-8.215548,"marketCap":63248641},{"date":"2024-08-16","current":-10.993719,"twenty":-13.216533,"median":-10.29298,"eighty":-8.15204,"marketCap":70975778},{"date":"2024-08-23","current":-13.004275,"twenty":-13.182439,"median":-10.833368,"eighty":-8.309008,"marketCap":83955991},{"date":"2024-08-30","current":-11.710317,"twenty":-13.188909,"median":-11.710317,"eighty":-8.610078,"marketCap":75602161},{"date":"2024-09-06","current":-12.939577,"twenty":-13.217965,"median":-12.391225,"eighty":-8.620371,"marketCap":83538300},{"date":"2024-09-13","current":-11.32213,"twenty":-13.217965,"median":-12.261039,"eighty":-9.289415,"marketCap":73096012},{"date":"2024-09-20","current":-11.483875,"twenty":-13.217965,"median":-11.710317,"eighty":-10.29298,"marketCap":74140241},{"date":"2024-09-27","current":-9.575287,"twenty":-13.210806,"median":-11.435351,"eighty":-9.575287,"marketCap":61818342},{"date":"2024-10-04","current":-9.727327,"twenty":-13.101322,"median":-11.354479,"eighty":-9.316172,"marketCap":62799917},{"date":"2024-10-11","current":-9.931126,"twenty":-13.068973,"median":-11.192735,"eighty":-9.413543,"marketCap":64115645},{"date":"2024-10-18","current":-9.769381,"twenty":-13.068973,"median":-10.859351,"eighty":-9.542938,"marketCap":63071416},{"date":"2024-10-25","current":-9.413543,"twenty":-13.004275,"median":-10.610453,"eighty":-9.542938,"marketCap":60774113},{"date":"2024-10-31","current":-8.782738,"twenty":-12.952517,"median":-10.592413,"eighty":-9.394069,"marketCap":56701621},{"date":"2024-11-08","current":-9.085848,"twenty":-12.836061,"median":-10.29298,"eighty":-9.218608,"marketCap":58658505},{"date":"2024-11-15","current":-7.116768,"twenty":-12.603148,"median":-10.141393,"eighty":-8.950952,"marketCap":45946065},{"date":"2024-11-22","current":-5.272053,"twenty":-12.423258,"median":-9.769381,"eighty":-8.605027,"marketCap":38782655},{"date":"2024-11-29","current":-6.178419,"twenty":-12.235002,"median":-9.759676,"eighty":-8.507772,"marketCap":45450128},{"date":"2024-12-06","current":-5.370028,"twenty":-11.917351,"median":-9.716005,"eighty":-8.143742,"marketCap":39503383},{"date":"2024-12-13","current":-12.876517,"twenty":-11.917351,"median":-9.704683,"eighty":-7.804035,"marketCap":94723165},{"date":"2024-12-20","current":-11.288606,"twenty":-11.937313,"median":-9.73218,"eighty":-8.125896,"marketCap":83042057},{"date":"2024-12-27","current":-14.738704,"twenty":-12.001827,"median":-9.761941,"eighty":-8.139646,"marketCap":108421919},{"date":"2025-01-03","current":-12.068126,"twenty":-12.384347,"median":-9.850254,"eighty":-8.168424,"marketCap":88776420},{"date":"2025-01-10","current":-14.782011,"twenty":-12.810182,"median":-10.086184,"eighty":-8.234384,"marketCap":108740495},{"date":"2025-01-17","current":-11.8949,"twenty":-12.876517,"median":-10.189917,"eighty":-8.475423,"marketCap":87502117},{"date":"2025-01-24","current":-8.430366,"twenty":-12.823449,"median":-10.125219,"eighty":-8.466412,"marketCap":62016063},{"date":"2025-01-31","current":-5.629868,"twenty":-12.632281,"median":-9.850254,"eighty":-8.128675,"marketCap":41414837},{"date":"2025-02-07","current":-5.600996,"twenty":-12.558673,"median":-9.759676,"eighty":-7.471942,"marketCap":41202453},{"date":"2025-02-14","current":-5.745352,"twenty":-12.423258,"median":-9.716005,"eighty":-6.985183,"marketCap":42264372},{"date":"2025-02-21","current":-5.456641,"twenty":-12.370592,"median":-9.688508,"eighty":-6.36129,"marketCap":40140534},{"date":"2025-02-28","current":-4.734863,"twenty":-12.322192,"median":-9.575287,"eighty":-6.039722,"marketCap":34830939},{"date":"2025-03-07","current":-4.850347,"twenty":-12.19815,"median":-9.413543,"eighty":-5.818713,"marketCap":35680475},{"date":"2025-03-14","current":-4.619378,"twenty":-12.093217,"median":-9.316172,"eighty":-5.658739,"marketCap":33981404},{"date":"2025-03-21","current":-4.590507,"twenty":-12.033481,"median":-9.267973,"eighty":-5.589448,"marketCap":33769021},{"date":"2025-03-28","current":-4.677121,"twenty":-11.941094,"median":-9.085848,"eighty":-5.445093,"marketCap":34406172},{"date":"2025-04-04","current":-3.682014,"twenty":-11.842932,"median":-9.000397,"eighty":-5.346931,"marketCap":32707102},{"date":"2025-04-11","current":-2.731469,"twenty":-11.788323,"median":-8.747948,"eighty":-5.012916,"marketCap":24263468},{"date":"2025-04-17","current":-3.828934,"twenty":-11.749136,"median":-8.669517,"eighty":-4.901959,"marketCap":34012183},{"date":"2025-04-25","current":-3.926486,"twenty":-11.61974,"median":-8.601309,"eighty":-4.833024,"marketCap":34878735},{"date":"2025-05-02","current":-4.706906,"twenty":-11.475058,"median":-8.516979,"eighty":-4.792605,"marketCap":41811155},{"date":"2025-05-09","current":-4.804459,"twenty":-11.45771,"median":-8.491597,"eighty":-4.792605,"marketCap":42677707},{"date":"2025-05-16","current":-4.048427,"twenty":-11.438586,"median":-8.234384,"eighty":-4.718089,"marketCap":35961926},{"date":"2025-05-23","current":-2.933033,"twenty":-11.406237,"median":-8.124506,"eighty":-4.677121,"marketCap":33145630},{"date":"2025-05-30","current":-3.928425,"twenty":-11.380358,"median":-7.63641,"eighty":-4.64825,"marketCap":44394361},{"date":"2025-06-06","current":-4.052742,"twenty":-11.348009,"median":-7.333748,"eighty":-4.596281,"marketCap":45799246},{"date":"2025-06-13","current":-4.574874,"twenty":-11.315425,"median":-7.167274,"eighty":-4.590507,"marketCap":51699762},{"date":"2025-06-20","current":-4.525147,"twenty":-11.288606,"median":-6.448552,"eighty":-4.525147,"marketCap":51137808},{"date":"2025-06-27","current":-4.500284,"twenty":-11.257432,"median":-6.245836,"eighty":-4.450557,"marketCap":50856831},{"date":"2025-07-03","current":-4.804944,"twenty":-11.153916,"median":-6.178419,"eighty":-4.480042,"marketCap":54299732},{"date":"2025-07-11","current":-4.384839,"twenty":-11.071717,"median":-6.001438,"eighty":-4.444649,"marketCap":49552214},{"date":"2025-07-18","current":-4.411096,"twenty":-11.057637,"median":-5.848373,"eighty":-4.413618,"marketCap":49848934},{"date":"2025-07-25","current":-5.118748,"twenty":-11.006503,"median":-5.726085,"eighty":-4.413618,"marketCap":57845975},{"date":"2025-08-01","current":-5.266689,"twenty":-10.886225,"median":-5.658739,"eighty":-4.423405,"marketCap":59517824},{"date":"2025-08-08","current":-5.177924,"twenty":-10.817778,"median":-5.632611,"eighty":-4.43502,"marketCap":58514715},{"date":"2025-08-15","current":-6.36145,"twenty":-10.649839,"median":-5.600996,"eighty":-4.43838,"marketCap":71889507},{"date":"2025-08-22","current":-5.360009,"twenty":-10.610453,"median":-5.567348,"eighty":-4.444649,"marketCap":76540639},{"date":"2025-08-29","current":-5.047341,"twenty":-10.610453,"median":-5.538676,"eighty":-4.449676,"marketCap":72075768},{"date":"2025-09-05","current":-4.667674,"twenty":-10.601601,"median":-5.456641,"eighty":-4.458388,"marketCap":66654139},{"date":"2025-09-12","current":-5.119065,"twenty":-10.582903,"median":-5.4212,"eighty":-4.477891,"marketCap":73099984},{"date":"2025-09-19","current":-4.897461,"twenty":-10.460155,"median":-5.370028,"eighty":-4.495136,"marketCap":69935483},{"date":"2025-09-26","current":-4.675856,"twenty":-10.329392,"median":-5.362697,"eighty":-4.515202,"marketCap":66770981},{"date":"2025-10-03","current":-4.409931,"twenty":-10.231142,"median":-5.325865,"eighty":-4.459866,"marketCap":62973579},{"date":"2025-10-10","current":-4.520733,"twenty":-10.170508,"median":-5.292169,"eighty":-4.471291,"marketCap":64555830},{"date":"2025-10-17","current":-4.099684,"twenty":-10.138159,"median":-5.266689,"eighty":-4.443146,"marketCap":58543277},{"date":"2025-10-24","current":-4.250282,"twenty":-10.078376,"median":-5.177924,"eighty":-4.421116,"marketCap":60693806},{"date":"2025-10-31","current":-4.156353,"twenty":-9.977535,"median":-5.177924,"eighty":-4.412988,"marketCap":59352507},{"date":"2025-11-07","current":-4.273765,"twenty":-9.834079,"median":-5.118748,"eighty":-4.402429,"marketCap":61029131},{"date":"2025-11-14","current":-4.273765,"twenty":-9.766275,"median":-5.104544,"eighty":-4.391176,"marketCap":61029131},{"date":"2025-11-21","current":-2.971008,"twenty":-9.761488,"median":-5.059977,"eighty":-4.38129,"marketCap":54322633},{"date":"2025-11-28","current":-3.447432,"twenty":-9.750618,"median":-5.0362,"eighty":-4.358965,"marketCap":63033690},{"date":"2025-12-05","current":-3.50521,"twenty":-9.73315,"median":-4.994703,"eighty":-4.321289,"marketCap":64090120},{"date":"2025-12-12","current":-3.909657,"twenty":-9.718269,"median":-4.969558,"eighty":-4.300776,"marketCap":71485134},{"date":"2025-12-19","current":-3.081503,"twenty":-9.704683,"median":-4.950787,"eighty":-4.273765,"marketCap":56342963},{"date":"2025-12-26","current":-2.927428,"twenty":-9.698213,"median":-4.936226,"eighty":-4.231496,"marketCap":53525815},{"date":"2026-01-02","current":-2.696315,"twenty":-9.672334,"median":-4.919621,"eighty":-4.226786,"marketCap":49300092},{"date":"2026-01-09","current":-2.965947,"twenty":-9.672334,"median":-4.910716,"eighty":-4.157441,"marketCap":54230102},{"date":"2026-01-16","current":-2.811872,"twenty":-9.575287,"median":-4.897871,"eighty":-4.145979,"marketCap":51412953},{"date":"2026-01-23","current":-2.831131,"twenty":-9.549408,"median":-4.897461,"eighty":-4.087363,"marketCap":51765097},{"date":"2026-01-30","current":-2.657797,"twenty":-9.439422,"median":-4.891008,"eighty":-3.973179,"marketCap":48595805},{"date":"2026-02-06","current":-2.445943,"twenty":-9.413543,"median":-4.875301,"eighty":-3.908145,"marketCap":44722227},{"date":"2026-02-13","current":-2.23409,"twenty":-9.413543,"median":-4.874269,"eighty":-3.823969,"marketCap":40848648},{"date":"2026-02-20","current":-2.311128,"twenty":-9.35512,"median":-4.850347,"eighty":-3.774842,"marketCap":42257222},{"date":"2026-02-27","current":-2.754094,"twenty":-9.300118,"median":-4.8312,"eighty":-3.691488,"marketCap":50356523},{"date":"2026-03-06","current":-2.908169,"twenty":-9.286254,"median":-4.804944,"eighty":-3.509217,"marketCap":53173671},{"date":"2026-03-13","current":-2.927428,"twenty":-9.264738,"median":-4.804459,"eighty":-3.458987,"marketCap":53525815},{"date":"2026-03-20","current":-2.888909,"twenty":-9.232389,"median":-4.792605,"eighty":-3.347283,"marketCap":52821528},{"date":"2026-03-27","current":-2.638537,"twenty":-9.139288,"median":-4.763734,"eighty":-3.283217,"marketCap":48243662},{"date":"2026-04-02","current":-1.869843,"twenty":-9.07459,"median":-4.734863,"eighty":-3.19573,"marketCap":53765188},{"date":"2026-04-10","current":-1.973708,"twenty":-9.037738,"median":-4.706449,"eighty":-3.15544,"marketCap":56751705},{"date":"2026-04-17","current":-2.046809,"twenty":-9.001875,"median":-4.699192,"eighty":-3.081503,"marketCap":58853620},{"date":"2026-04-24","current":-2.119909,"twenty":-8.908899,"median":-4.683564,"eighty":-3.034837,"marketCap":60955535},{"date":"2026-05-01","current":-2.485411,"twenty":-8.768822,"median":-4.677121,"eighty":-2.985206,"marketCap":71465110},{"date":"2026-05-08","current":-2.485411,"twenty":-8.7364,"median":-4.657962,"eighty":-2.965947,"marketCap":71465110},{"date":"2026-05-15","current":-2.748572,"twenty":-8.699253,"median":-4.619378,"eighty":-2.954392,"marketCap":79032004},{"date":"2026-05-22","current":-2.169023,"twenty":-8.649859,"median":-4.610947,"eighty":-2.927428,"marketCap":76509706},{"date":"2026-05-29","current":-2.500026,"twenty":-8.617798,"median":-4.590507,"eighty":-2.912021,"marketCap":88185449},{"date":"2026-06-05","current":-2.335883,"twenty":-8.605027,"median":-4.574874,"eighty":-2.888909,"marketCap":82395496},{"date":"2026-06-12","current":-2.159113,"twenty":-8.590585,"median":-4.542637,"eighty":-2.850391,"marketCap":76160161},{"date":"2026-06-18","current":-2.17174,"twenty":-8.57247,"median":-4.525147,"eighty":-2.831131,"marketCap":76605542},{"date":"2026-06-26","current":-2.272751,"twenty":-8.516979,"median":-4.520733,"eighty":-2.811872,"marketCap":80168590},{"date":"2026-07-02","current":-2.285377,"twenty":-8.509613,"median":-4.508587,"eighty":-2.790024,"marketCap":80613971},{"date":"2026-07-10","current":-2.17174,"twenty":-8.507772,"median":-4.481912,"eighty":-2.769501,"marketCap":76605542},{"date":"2026-07-17","current":-1.893959,"twenty":-8.481893,"median":-4.461622,"eighty":-2.745824,"marketCap":66807159},{"date":"2026-07-24","current":-1.969717,"twenty":-8.439377,"median":-4.448354,"eighty":-2.715575,"marketCap":69479445},{"date":"2026-07-31","current":-1.969717,"twenty":-8.312777,"median":-4.438389,"eighty":-2.696315,"marketCap":69479445},{"date":"2026-08-07","current":-2.058102,"twenty":-8.184914,"median":-4.437352,"eighty":-2.657797,"marketCap":72597112},{"date":"2026-08-14","current":-2.020223,"twenty":-8.139646,"median":-4.419971,"eighty":-2.618363,"marketCap":71260969},{"date":"2026-08-21","current":-1.787426,"twenty":-8.123117,"median":-4.411096,"eighty":-2.573055,"marketCap":70370207}],"updateTime":1787617884374},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649386379","title":"OS Therapies Incorporated (OSTX) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2649386379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649386379?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:05","pubTimestamp":1783429534,"startTime":"0","endTime":"0","summary":"Lake Street analyst Chad Messer maintained a Buy rating on OS Therapies Incorporated today and set a price target of $13.00. Messer covers the Heal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/os-therapies-incorporated-ostx-gets-a-buy-from-lake-street-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/os-therapies-incorporated-ostx-gets-a-buy-from-lake-street-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649684624","title":"OS Therapies Enters USD 10 Million Line of Credit Backed by U.K. VAT, R&D Tax Credits","url":"https://stock-news.laohu8.com/highlight/detail?id=2649684624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649684624?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:02","pubTimestamp":1783342930,"startTime":"0","endTime":"0","summary":"OS Therapies enters USD 10 million line of credit backed by U.K. VAT, R&D tax creditsOS Therapies entered a USD 10 million line of credit backed by VAT reimbursements and R&D tax credits at its UK sub","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL1rHv3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648636845","title":"OS Therapies Secures Convertible Note Financing for Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636845?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:10","pubTimestamp":1783026652,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) has issued an announcement. On June 30, 2026, OS Therapies and its subsidiaries entered a private placement w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-secures-convertible-note-financing-for-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-secures-convertible-note-financing-for-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648363354","title":"Os Therapies - Enters Agreement for up to $10 Mln Senior Secured Convertible Note on June 30- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648363354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648363354?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:32","pubTimestamp":1783024367,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504477","title":"OS Therapies Names Chief Medical Advisor Craig Eagle to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504477","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648504477?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:32","pubTimestamp":1782991926,"startTime":"0","endTime":"0","summary":"OS Therapies names Chief Medical Advisor Craig Eagle to boardOS Therapies appointed Chief Medical Advisor Craig Eagle to its board, replacing departing director Karim Galzahr, who will remain on the a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLlcCpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647558249","title":"OS Therapies Seeks FDA Alignment on 3-year Overall Survival Endpoint for Ost-her2 Accelerated Approval Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2647558249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647558249?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:41","pubTimestamp":1782819688,"startTime":"0","endTime":"0","summary":"OS Therapies seeks FDA alignment on 3-year overall survival endpoint for OST-HER2 accelerated approval bidOS Therapies requested an FDA Type B meeting to support an accelerated-approval filing for OST","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL1Bnqcb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646541723","title":"OS Therapies Unit OS Animal Health Posts Peer-reviewed Data for Ost-her2 in Canine Osteosarcoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2646541723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646541723?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:41","pubTimestamp":1782474081,"startTime":"0","endTime":"0","summary":"OS Therapies unit OS Animal Health posts peer-reviewed data for OST-HER2 in canine osteosarcoma trialOS Animal Health, the wholly owned animal-health subsidiary of OS Therapies, reported peer-reviewed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL4jD20J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640590045","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640590045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640590045?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:10","pubTimestamp":1780495808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Axsome Therapeutics (AXSM) and OS Therapies Incorpor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-204?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-204?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","BK4139","BK4585","OSTX","BK4505","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911759","title":"OS Therapies says OST-HER2 Phase 2b trial posts 75% 2.5-year survival in resected metastatic osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640911759?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:01","pubTimestamp":1780394516,"startTime":"0","endTime":"0","summary":"OS Therapies reported its Phase 2b OST-HER2 study in fully resected pulmonary metastatic osteosarcoma showed a clearer survival benefit versus historical comparisons.Updated findings have not yet been presented; detailed results are slated for release at a late-June 2026 osteosarcoma conference.The company is adding the updated data to regulatory filings, targeting early market authorizations across major Western markets in 2H 2026.Regulators in Europe and Australia have aligned on using upcoming 3-year survival results, expected in early Q4 2026, as a key endpoint.A confirmatory Phase 3 trial is expected to start in late Q3 2026 in Australia, a prerequisite for early market access.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL8y7q6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639624674","title":"OS Therapies to release 2.5-year overall survival data from Phase 2b OST-HER2 osteosarcoma trial at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639624674","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639624674?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:21","pubTimestamp":1780053677,"startTime":"0","endTime":"0","summary":"OS Therapies flagged an upcoming release of 2.5-year overall survival results from its Phase 2b OST-HER2 osteosarcoma trial.Data will be presented at the 2026 ASCO Annual Meeting running May 28 to June 2, 2026; results have not yet been disclosed.The readout targets whether OST-HER2 can prevent or delay recurrence following full surgical removal of pulmonary metastatic osteosarcoma.The company reiterated plans to seek a U.S. accelerated-approval BLA in the second half of 2026, with parallel filings planned abroad.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLlzQ61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638115405","title":"OS Therapies to present 2.5-year overall survival data at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638115405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638115405?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:41","pubTimestamp":1779795679,"startTime":"0","endTime":"0","summary":"OS Therapies plans to present 2.5-year overall survival data at ASCO 2026 in Chicago, May 29-June 2, 2026.Executives are scheduled for partnering and select investor meetings at the Jefferies Global Healthcare Conference in New York, June 2-4, 2026.OS Therapies is due to present data at the MIB Agents Factor Osteosarcoma Conference in Columbus, June 25-27, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL59XVCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637908821","title":"Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and OS Therapies Incorporated (OSTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637908821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637908821?lang=en_us&edition=fundamental","pubTime":"2026-05-21 00:40","pubTimestamp":1779295209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Guardant Health (GH) and OS Therapies Incorporated (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-guardant-health-gh-and-os-therapies-incorporated-ostx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-guardant-health-gh-and-os-therapies-incorporated-ostx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","LABU","BK4196","LU0029874061.USD","LU0128526141.USD","BK4139","BK4535","BK4588","BK4585","OSTX","XLV","XBI","GH","BK4551","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636852967","title":"OS Therapies Is Maintained at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2636852967","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636852967?lang=en_us&edition=fundamental","pubTime":"2026-05-19 22:14","pubTimestamp":1779200040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OSTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2026 10:14 ET (14:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636741859","title":"OS Therapies price target lowered to $13 from $14 at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2636741859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636741859?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:45","pubTimestamp":1779194731,"startTime":"0","endTime":"0","summary":"Lake Street lowered the firm’s price target on OS Therapies (OSTX) to $13 from $14 and keeps a Buy rating on the shares following the company’s Q1 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-price-target-lowered-to-13-from-14-at-lake-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-price-target-lowered-to-13-from-14-at-lake-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636998022","title":"OS Therapies Q1 EPS $(0.27) Misses $(0.18) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2636998022","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636998022?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:37","pubTimestamp":1779100669,"startTime":"0","endTime":"0","summary":"OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.18) by 50 percent. This is a 50 percent decrease over losses of $(0.18) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52628803/os-therapies-q1-eps-0-27-misses-0-18-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636024377","title":"OS Therapies Q1 FY26 net loss widens to $10.4 million; no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2636024377","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636024377?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:06","pubTimestamp":1779098791,"startTime":"0","endTime":"0","summary":"OS Therapies posted a net loss of USD 10.4 million for the three months ended March 31, 2026, widening from USD 3.9 million a year earlier as the operating loss grew to USD 10.17 million from USD 5 million.Research and development expense climbed to USD 7.35 million from USD 1.31 million, while general and administrative expense fell to USD 2.82 million from USD 3.69 million.Other expense totaled USD 228,893 versus other income of USD 1.12 million, reflecting USD 75,344 of interest expense and USD 153,594 of non-operating expense; there was no revenue in either period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL3mpSjd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635056321","title":"OS Therapies Delays Quarterly SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635056321","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635056321?lang=en_us&edition=fundamental","pubTime":"2026-05-16 07:30","pubTimestamp":1778887821,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) has released a notification of late filing. OS Therapies Incorporated has filed a Form 12b-25 notifying inves...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-delays-quarterly-sec-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-delays-quarterly-sec-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635303250","title":"OS Therapies delays filing quarterly report after close process takes longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2635303250","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635303250?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:25","pubTimestamp":1778876701,"startTime":"0","endTime":"0","summary":"OS Therapies filed a Form 12b-25 to delay its quarterly report on Form 10-Q for period ended March 31, 2026.Filing missed May 15 due date due to delays in compiling and reviewing information tied to a longer financial close process.Report expected within five calendar days of original deadline under SEC Rule 12b-25.Notice indicated no anticipated significant change in results of operations versus the year-earlier quarter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL8LHvw7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037956","title":"OS Therapies to report Q1 2026 financial results, give business update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037956?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:07","pubTimestamp":1778875642,"startTime":"0","endTime":"0","summary":"OS Therapies to release first-quarter 2026 financial results, followed by business update, on Monday, May 18, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL7KBg36:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635244596","title":"Stonegate Capital Partners updates coverage on OS Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635244596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635244596?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:36","pubTimestamp":1778610977,"startTime":"0","endTime":"0","summary":"Stonegate Capital Partners updated coverage on OS Therapies, citing increased regulatory visibility for lead candidate OST-HER2 in recurrent, fully resected pulmonary metastatic osteosarcoma.EMA initiated a rolling review for a Conditional Marketing Authorization dossier, while EMA and Australia’s TGA aligned on 3-year overall survival as approvable efficacy endpoint.Focus shifts to upcoming survival readouts, with 2.5-year overall survival data due mid-2Q26 and 3-year data expected early 4Q26 ahead of a potential EMA CMA decision in 4Q26.Funding runway highlighted, including a USD 5.25 million raise and an expected USD 4 million in non-dilutive funding, with a potential priority review voucher cited as additional approval-contingent upside.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL4d2ZM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":63,"code":"91000000","status":"200"}]}}